Pyrazinamide (Z)
Sponsors
Global Alliance for TB Drug Development, University of Oxford, University College, London, Shenzhen Third People's Hospital
Conditions
Pulmonary TuberculosisTuberculosisTuberculosis (TB)
Phase 1
Phase 2
Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)
CompletedNCT01498419
Start: 2012-03-31End: 2013-07-31Updated: 2018-06-28
Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)
CompletedNCT01691534
Start: 2012-10-31End: 2013-05-31Updated: 2016-12-13
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
RecruitingNCT06114628
Start: 2024-01-09End: 2027-08-11Target: 2500Updated: 2025-10-06
Phase 3
A PAN-USR TB Multi-Center Trial
RecruitingNCT06905522
Start: 2025-06-18End: 2029-12-31Target: 610Updated: 2025-12-01
Ultra-Short Regimen for Elderly DS-TB
Not yet recruitingNCT07076225
Start: 2025-07-25End: 2030-07-31Target: 300Updated: 2025-07-22
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Not yet recruitingNCT07163143
Start: 2025-11-30End: 2029-04-30Target: 784Updated: 2025-09-09